Using an authentic mouse model of lung cancer, we show, for the first time, that PDLIM2 nanotherapy shows efficacy and high safety, and more importantly, induces complete remission of all lung tumors in most animals when it is combined with anti-PD-1 and chemotherapeutic drugs. Here, PDLIM2 is linked to lung cancer.